146 filings
Page 2 of 8
6-K
9g8hbnl
17 May 23
BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights
7:30am
6-K
34z5xupf bvb73qg
20 Mar 23
Current report (foreign)
4:01pm
6-K
me2xs7zgmfj 5dm
15 Mar 23
BrainsWay Reports Fourth Quarter and Full-Year 2022 Financial Results and Operational Highlights
7:30am
6-K
m9qc92ifu2qgp4
13 Feb 23
Notice of Annual General Meeting of Shareholders
4:01pm
6-K
dr8lij fq
13 Feb 23
BrainsWay Announces Appointment of Ami Boehm as New Chairman
7:30am
6-K
lh0ws
13 Feb 23
BrainsWay Announces Appointment of Hadar Levy as CEO
7:30am
6-K
y10ofkg5b4vl
12 Jan 23
BrainsWay Appoints Ami Boehm as Board Member
8:01am
6-K
59dkf
10 Jan 23
Current report (foreign)
8:00am
6-K
8o4yv3dym7le8ogi1
28 Nov 22
BrainsWay Reports Open Market Stock Purchases by Two Board Members
7:31am
6-K
4blyekde9l
16 Nov 22
BrainsWay Reports Third Quarter 2022 Financial Results and Operational Highlights
7:30am
6-K
x4k1 kdutf
14 Sep 22
Current report (foreign)
7:30am
6-K
yhdx2cq9pk1f
29 Aug 22
BrainsWay Receives New FDA Clearance for Treating Depression and Anxious Depression
8:00am
6-K
3q15b vil9y2wo0cqjf
10 Aug 22
BrainsWay Reports Second Quarter 2022 Financial Results and Operational Highlights
7:30am
6-K
rk9oc wytqkjz
28 Jun 22
BrainsWay Announces Insurance Coverage by Israeli Ministry of Health for the Treatment of Depression
8:00am
6-K
81fo4
11 May 22
BrainsWay Reports First Quarter 2022 Financial Results and Operational Highlights
7:30am
6-K
wbgyp
9 Mar 22
BrainsWay Reports Fourth Quarter and Full-Year 2021 Financial Results and Operational Highlights
7:30am
6-K
c8dhg 0pbr1o7qm9cg
31 Jan 22
Current report (foreign)
7:30am
6-K
vsanv wnfn
23 Dec 21
Current report (foreign)
8:00am